The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Harmony Biosciences Holdings, Inc(NASDAQ:HRMY) 
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United Sta...
Website: https://www.harmonybiosciences.com/
Founded: 2017
Full Time Employees: 150
CEO: John C.s Jacobs
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Harmony Biosciences Days Payable Outstanding ttm (DPO)
Harmony Biosciences Days Receivable Outstanding ttm (DSO)
Harmony Biosciences Days Inventory Outstanding ttm (DIO)
Harmony Biosciences Op Cashflow Per Share ttm
Harmony Biosciences Free Cashflow Per Share ttm
Harmony Biosciences Cash Per Share ttm
Harmony Biosciences P/S ratio ttm
Harmony Biosciences (GAAP) P/E ratio ttm
Harmony Biosciences P/B ratio ttm
No extra charts and metrics for this ticker.